title: Aspirin for the primary prevention of cardiovascular disease: a comprehensive review.
abstract: Aspirin use for the primary prevention of cardiovascular disease should be targeted to patients with a high cardiovascular risk. Physicians should assess the risks and benefits of aspirin therapy for primary prevention and incorporate patient preferences.
authors.affiliation: Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA. Nicolas.Rodondi@hospvd.ch
authors.forename: Nicolas
authors.initials: N
authors.lastname: Rodondi
authors.forename: Jacques
authors.initials: J
authors.lastname: Cornuz
authors.forename: Douglas C
authors.initials: DC
authors.lastname: Bauer
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002543:Cerebral Hemorrhage / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006801:Humans; D010358:Patient Participation; D011322:Primary Prevention; D018570:Risk Assessment
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin